During the past decade, Diagnostic Group conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Diagnostic Group" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Diagnostic Group" are "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "Diagnostic Group" in a lesser frequency.

Most popular intervention types in "Diagnostic Group" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Filgotinib" (1 trials), "Methotrexate (MTX)" (1 trials), "Placebo (PBO)" (1 trials), "Placebo to match filgotinib" (1 trials) and "Tocilizumab (TCZ)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diagnostic Group" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Diagnostic Group". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Diagnostic Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Diagnostic Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".